Results from the tranexamic acid for primary intracerebral haemorrhage-2 (TICH-2) trial
Background: Haematoma expansion leads to worse outcome in intracerebral haemorrhage (ICH). Tranexamic acid (TXA) is a promising haemostatic agent to prevent haematoma expansion and improve outcome after ICH. Methods: TICH-2 is a multicentre prospective double blind randomised controlled trial, whic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Published: |
2018
|
| Online Access: | https://eprints.nottingham.ac.uk/51139/ |